The Depressed Frail Phenotype: The Clinical Manifestation of Increased Biological Aging

Published on Nov 1, 2016in American Journal of Geriatric Psychiatry3.49
· DOI :10.1016/j.jagp.2016.06.005
Patrick J. Brown14
Estimated H-index: 14
(Columbia University),
Bret R. Rutherford18
Estimated H-index: 18
(Columbia University)
+ 5 AuthorsSteven P. Roose52
Estimated H-index: 52
(Columbia University)
Depression in later life is a severe public health problem, associated with higher rates of mortality, suicide, and dementia. Effectiveness of treatment is limited by the failure to deconstruct the heterogeneity of the illness and because diagnostic criteria, pathophysiological models, and treatment algorithms for depression are primarily based on studies of younger adults even though symptoms of the illness and physiology of the patient change with age. Thus, understanding how aging interacts with depressive illness may elucidate endophenotypes of late-life depression with different clinical manifestations and underlying mechanisms that can then be targeted with more personalized approaches to treatment. This paper proposes a model for the critical confluence between depression and frailty, a high-risk morbidity and mortality syndrome of later life. This model hypothesizes that characteristics of frailty in adults with late life depression represent the clinical manifestation of greater biological aging and their presence in the context of a depressive illness exposes elders to deleterious trajectories. Potential common biological substrates that may result in the manifestation of the depressed frail phenotype including mitochondrial functioning, dopaminergic neurotransmission, and inflammatory processes and implications for the assessment and treatment of adults with late-life depression are discussed. As society continues to live longer, the preservation of the quality of these added years becomes paramount, and the combined impact of depression and frailty on the preservation of this quality warrants the attention of clinical researchers and physicians.
  • References (76)
  • Citations (15)
#1Patrick J. Brown (Columbia University)H-Index: 14
#2Steven P. Roose (Columbia University)H-Index: 52
Last.Suzanne Satterfield (UTHSC: University of Tennessee Health Science Center)H-Index: 62
view all 10 authors...
#1Cristina Buigues (University of Valencia)H-Index: 5
#2Celia Padilla-Sánchez (University of Valencia)H-Index: 1
Last.Omar Cauli (University of Valencia)H-Index: 30
view all 6 authors...
#1Daniel Lindqvist (UCSF: University of California, San Francisco)H-Index: 18
#2Elissa S. Epel (UCSF: University of California, San Francisco)H-Index: 68
Last.Christina M. Hough (UCSF: University of California, San Francisco)H-Index: 7
view all 10 authors...
#1Na Cai (Wellcome Trust Centre for Human Genetics)H-Index: 8
#2Simon Chang (CGU: Chang Gung University)H-Index: 2
Last.Jérôme Nicod (Wellcome Trust Centre for Human Genetics)H-Index: 13
view all 10 authors...
#1Lesley M. Arnold (University of Cincinnati Academic Health Center)H-Index: 48
#2Thomas J. Blom (University of Cincinnati Academic Health Center)H-Index: 12
Last.Alicia Heller (University of Cincinnati Academic Health Center)H-Index: 1
view all 5 authors...
Cited By15
#1Breno S. Diniz (U of T: University of Toronto)H-Index: 34
#2Charles F. Reynolds (University of Pittsburgh)H-Index: 102
Last.Brenda W. J. H. Penninx (PHRI: Public Health Research Institute)H-Index: 126
view all 5 authors...
#1Patrick J. Brown (Columbia University)H-Index: 14
#2Nicholas Brennan (NIH: National Institutes of Health)
Last.Richard G. Spencer (NIH: National Institutes of Health)H-Index: 30
view all 10 authors...
#1Vincenzo Solfrizzi (University of Bari)H-Index: 53
#2Emanuele Scafato (ISS: Istituto Superiore di Sanità)H-Index: 29
Last.Marzia Baldereschi (National Research Council)H-Index: 29
view all 10 authors...
#1Jennifer Sutton ('KCL': King's College London)H-Index: 1
#2Rebecca L. Gould (UCL: University College London)H-Index: 13
Last.Robert Howard (UCL: University College London)H-Index: 65
view all 10 authors...
View next paperPharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial